ILLUMINA, INC.ILMNEarnings & Financial Report
Nasdaq · Industrials · Laboratory Analytical Instruments
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 11.30% | 18.1M | ▲ +2.90pp | 2024-07-08 |
| OF ABOVE PERSONS | 10.60% | 16.8M | — | 2024-12-05 |
| The Vanguard Group | 10.05% | 15.9M | ▲ +0.07pp | 2024-12-06 |
| Nos. of above persons | 3.36% | 5.3M | ▼ -2.08pp | 2023-12-05 |
Insider Transactions
Net 90d: −$407.0K · buys $23.6K / sells $430.6KRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-31 | Meister Keith A. | Director | Grant | 161 | $131.55 | $21.2K |
| 2026-03-31 | Ullem Scott B. | Director | Grant | 190 | $131.55 | $25.0K |
| 2026-03-05 | Steven Barnard | SVP, Chief Technology Officer | Grant | 7.6K | $128.24 | $975.0K |
| 2026-03-05 | Ericksen Scott D | VP, Chief Accounting Officer | Grant | 3.2K | $128.24 | $412.5K |
| 2026-03-05 | Ankur Dhingra | SVP, Chief Financial Officer | Grant | 9.4K | $128.24 | $1.20M |
| 2026-03-05 | Patricia Leckman | SVP, Chief People Officer | Grant | 6.3K | $128.24 | $810.1K |
| 2026-03-05 | Jacob Thaysen | Chief Executive Officer | Grant | 25.7K | $128.24 | $3.30M |
| 2026-03-05 | Pegels Kevin Carl | Chief of Global Operations | Grant | 6.3K | $128.24 | $810.1K |
| 2026-03-05 | Wedel Christensen Jakob | SVP, Strategy/Corp Development | Grant | 5.6K | $128.24 | $720.1K |
| 2026-03-05 | Davies Scott M | Chief Legal Officer | Grant | 5.8K | $128.24 | $750.1K |
1–10 of 20
Page 1 / 2